Canada markets closed

ImmuPharma PLC (25I.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.0205+0.0005 (+2.50%)
At close: 04:31PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
69.959
0
118.35
126.667
Operating Expenses
Research Development
1,808
2,023
3,650
2,373
Selling General and Administrative
703.248
846.571
1,011
1,765
Total Operating Expenses
2,728
3,029
5,278
5,716
Operating Income or Loss
-2,658
-3,029
-5,160
-5,589
Interest Expense
-173.698
2.036
124.063
230.828
Income Before Tax
-3,764
-4,456
-8,941
-7,246
Income Tax Expense
-772.569
-648.902
-766.814
-386.248
Income from Continuing Operations
-2,991
-3,807
-8,174
-6,860
Net Income
-2,991
-3,807
-8,174
-6,860
Net Income available to common shareholders
-2,991
-3,807
-8,174
-6,860
Basic EPS
-0.01
-0.01
-0.03
-0.03
Diluted EPS
-0.01
-0.01
-0.03
-0.03
Basic Average Shares
327,122
302,913
251,164
200,176
Diluted Average Shares
327,122
302,913
251,164
200,176